Key result
In patients with type 2 diabetes, a C4CV >11.4% was associated with a significantly higher risk of macrovascular events compared to a C4CV <4.3% (HR 2.13; 95% CI 1.70-2.67).
Why the study?
It was unknown whether the coefficient of variation of the fourth harmonic amplitude of the radial pulse wave (C4CV) predicts the risk of macrovascular and microvascular events in patients with T2DM.
Does a high coefficient of variation of the fourth harmonic amplitude of the radial pulse wave (C4CV) predict macrovascular and microvascular events in patients with type 2 diabetes mellitus?
Cohort (n=2,324)
Does a high coefficient of variation of the fourth harmonic amplitude of the radial pulse wave (C4CV) predict macrovascular and microvascular events in patients with type 2 diabetes mellitus?
Hazard Ratio: 2.13 (95% CI 1.7–2.67)
p-value: p=< 0.0001
C4CV derived from radial pulse wave analysis is a novel independent predictor of cardiovascular mortality and vascular events in patients with type 2 diabetes.
C4CV may stratify macrovascular risk in T2DM; leaves open its incremental value beyond standard predictors in prospective studies.
This investigation explored the hypothesis that whether the coefficient of variation of the fourth harmonic amplitude of the radial pulse wave (C4CV) predicts the risk of macrovascular and microvascular events in patients with type 2 diabetes mellitus (T2DM). Radial pulse wave and brachial blood pressure were measured at baseline in 2324 patients with T2DM and C4CV was calculated using the Fourier series method. Macrovascular and microvascular events during follow-up were determined by medical records. We plotted the Kaplan-Meier curve and performed a Cox proportional hazard model and a log-rank test to estimate the effectiveness of C4CV as a risk predictor. We divided patients into quartile groups based on C4CV (<4.3%, 4.3% to 6.8%, 6.8% to 11.4%, and >11.4%). Compared with patients with C4CV < 4.3%, patients with C4CV> 11.4% had a double incidence of macrovascular events (hazard ratio, 2.13; 95% CI, 1.70-2.67) and microvascular events (hazard ratio, 2.08; 95% CI, 1.67-2.58), and the incidence of cardiovascular death was three times (hazard ratio, 3.03; 95% CI, 1.10-8.83). The Cox regression analysis demonstrated that the risk of both macrovascular and microvascular outcomes increases with the increase in quartile level of C4CV value (P < 0.0001). These associations remained after adjustment for age, gender, smoking, systolic blood pressure, diastolic blood pressure, dyslipidemia, diabetes duration, Hba1c, and cardiovascular disease (P < 0.0001). C4CV is a novel independent predictor of cardiovascular mortality, macrovascular events, and microvascular events in patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2019) conducted a cohort in Type 2 diabetes mellitus (n=2,324). C4CV > 11.4% vs. C4CV < 4.3% was evaluated on Macrovascular events (HR 2.13, 95% CI 1.70-2.67, p=< 0.0001). In patients with type 2 diabetes, a C4CV >11.4% was associated with a significantly higher risk of macrovascular events compared to a C4CV <4.3% (HR 2.13; 95% CI 1.70-2.67).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: